Report Cover

Global Antibody-drug Conjugates Market Insights and Forecast to 2027


Antibody-drug Conjugates market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antibody-drug Conjugates market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
    Adcetris
    Kadcyla

Segment by Application
    Breast Cancer
    Lymphoma

By Company
    ImmunoGen
    Seattle Genetics
    Roche
    Takeda

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
1 Study Coverage
    1.1 Antibody-drug Conjugates Product Introduction
    1.2 Market by Type
        1.2.1 Global Antibody-drug Conjugates Market Size Growth Rate by Type
        1.4.2 Adcetris
        1.4.3 Kadcyla
    1.3 Market by Application
        1.3.1 Global Antibody-drug Conjugates Market Size Growth Rate by Application
        1.3.2 Breast Cancer
        1.3.3 Lymphoma
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
    2.1 Global Antibody-drug Conjugates Sales Estimates and Forecasts 2016-2027
    2.2 Global Antibody-drug Conjugates Revenue Estimates and Forecasts 2016-2027
    2.3 Global Antibody-drug Conjugates Revenue by Region: 2016 VS 2021 VS 2027
    2.4 Global Top Antibody-drug Conjugates Regions by Sales
        2.4.1 Global Top Antibody-drug Conjugates Regions by Sales (2016-2021)
        2.4.2 Global Top Antibody-drug Conjugates Regions by Sales (2022-2027)
    2.5 Global Top Antibody-drug Conjugates Regions by Revenue
        2.5.1 Global Top Antibody-drug Conjugates Regions by Revenue (2016-2021)
        2.5.2 Global Top Antibody-drug Conjugates Regions by Revenue (2022-2027)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Antibody-drug Conjugates Sales by Manufacturers
        3.1.1 Global Top Antibody-drug Conjugates Manufacturers by Sales (2016-2021)
        3.1.2 Global Top Antibody-drug Conjugates Manufacturers Market Share by Sales (2016-2021)
        3.1.3 Global Top 10 and Top 5 Companies by Antibody-drug Conjugates Sales in 2020
    3.2 Global Antibody-drug Conjugates Revenue by Manufacturers
        3.2.1 Global Top Antibody-drug Conjugates Manufacturers by Revenue (2016-2021)
        3.2.2 Global Top Antibody-drug Conjugates Manufacturers Market Share by Revenue (2016-2021)
        3.2.3 Global Top 10 and Top 5 Companies by Antibody-drug Conjugates Revenue in 2020
    3.3 Global Antibody-drug Conjugates Sales Price by Manufacturers
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Antibody-drug Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Antibody-drug Conjugates Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
    4.1 Global Antibody-drug Conjugates Sales by Type
        4.1.1 Global Antibody-drug Conjugates Historical Sales by Type (2016-2021)
        4.1.2 Global Antibody-drug Conjugates Forecasted Sales by Type (2022-2027)
        4.1.3 Global Antibody-drug Conjugates Sales Market Share by Type (2016-2027)
    4.2 Global Antibody-drug Conjugates Revenue by Type
        4.2.1 Global Antibody-drug Conjugates Historical Revenue by Type (2016-2021)
        4.2.2 Global Antibody-drug Conjugates Forecasted Revenue by Type (2022-2027)
        4.2.3 Global Antibody-drug Conjugates Revenue Market Share by Type (2016-2027)
    4.3 Global Antibody-drug Conjugates Price by Type
        4.3.1 Global Antibody-drug Conjugates Price by Type (2016-2021)
        4.3.2 Global Antibody-drug Conjugates Price Forecast by Type (2022-2027)
5 Market Size by Application
    5.1 Global Antibody-drug Conjugates Sales by Application
        5.1.1 Global Antibody-drug Conjugates Historical Sales by Application (2016-2021)
        5.1.2 Global Antibody-drug Conjugates Forecasted Sales by Application (2022-2027)
        5.1.3 Global Antibody-drug Conjugates Sales Market Share by Application (2016-2027)
    5.2 Global Antibody-drug Conjugates Revenue by Application
        5.2.1 Global Antibody-drug Conjugates Historical Revenue by Application (2016-2021)
        5.2.2 Global Antibody-drug Conjugates Forecasted Revenue by Application (2022-2027)
        5.2.3 Global Antibody-drug Conjugates Revenue Market Share by Application (2016-2027)
    5.3 Global Antibody-drug Conjugates Price by Application
        5.3.1 Global Antibody-drug Conjugates Price by Application (2016-2021)
        5.3.2 Global Antibody-drug Conjugates Price Forecast by Application (2022-2027)

6 North America
    6.1 North America Antibody-drug Conjugates Market Size by Type
        6.1.1 North America Antibody-drug Conjugates Sales by Type (2016-2027)
        6.1.2 North America Antibody-drug Conjugates Revenue by Type (2016-2027)
    6.2 North America Antibody-drug Conjugates Market Size by Application
        6.2.1 North America Antibody-drug Conjugates Sales by Application (2016-2027)
        6.2.2 North America Antibody-drug Conjugates Revenue by Application (2016-2027)
    6.3 North America Antibody-drug Conjugates Market Size by Country
        6.3.1 North America Antibody-drug Conjugates Sales by Country (2016-2027)
        6.3.2 North America Antibody-drug Conjugates Revenue by Country (2016-2027)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Antibody-drug Conjugates Market Size by Type
        7.1.1 Europe Antibody-drug Conjugates Sales by Type (2017-2027)
        7.1.2 Europe Antibody-drug Conjugates Revenue by Type (2017-2027)
    7.2 Europe Antibody-drug Conjugates Market Size by Application
        7.2.1 Europe Antibody-drug Conjugates Sales by Application (2017-2027)
        7.2.2 Europe Antibody-drug Conjugates Revenue by Application (2017-2027)
    7.3 Europe Antibody-drug Conjugates Market Size by Country
        7.3.1 Europe Antibody-drug Conjugates Sales by Country (2017-2027)
        7.3.2 Europe Antibody-drug Conjugates Revenue by Country (2017-2027)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Antibody-drug Conjugates Market Size by Type
        8.1.1 Asia Pacific Antibody-drug Conjugates Sales by Type (2018-2027)
        8.1.2 Asia Pacific Antibody-drug Conjugates Revenue by Type (2018-2027)
    8.2 Asia Pacific Antibody-drug Conjugates Market Size by Application
        8.2.1 Asia Pacific Antibody-drug Conjugates Sales by Application (2018-2027)
        8.2.2 Asia Pacific Antibody-drug Conjugates Revenue by Application (2018-2027)
    8.3 Asia Pacific Antibody-drug Conjugates Market Size by Region
        8.3.1 Asia Pacific Antibody-drug Conjugates Sales by Region (2018-2027)
        8.3.2 Asia Pacific Antibody-drug Conjugates Revenue by Region (2018-2027)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Antibody-drug Conjugates Market Size by Type
        9.1.1 Latin America Antibody-drug Conjugates Sales by Type (2019-2027)
        9.1.2 Latin America Antibody-drug Conjugates Revenue by Type (2019-2027)
    9.2 Latin America Antibody-drug Conjugates Market Size by Application
        9.2.1 Latin America Antibody-drug Conjugates Sales by Application (2019-2027)
        9.2.2 Latin America Antibody-drug Conjugates Revenue by Application (2019-2027)
    9.3 Latin America Antibody-drug Conjugates Market Size by Country
        9.3.1 Latin America Antibody-drug Conjugates Sales by Country (2019-2027)
        9.3.2 Latin America Antibody-drug Conjugates Revenue by Country (2019-2027)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
6 Middle East and Africa
    6.1 Middle East and Africa Antibody-drug Conjugates Market Size by Type
        6.1.1 Middle East and Africa Antibody-drug Conjugates Sales by Type (2016-2027)
        6.1.2 Middle East and Africa Antibody-drug Conjugates Revenue by Type (2016-2027)
    6.2 Middle East and Africa Antibody-drug Conjugates Market Size by Application
        6.2.1 Middle East and Africa Antibody-drug Conjugates Sales by Application (2016-2027)
        6.2.2 Middle East and Africa Antibody-drug Conjugates Revenue by Application (2016-2027)
    6.3 Middle East and Africa Antibody-drug Conjugates Market Size by Country
        6.3.1 Middle East and Africa Antibody-drug Conjugates Sales by Country (2016-2027)
        6.3.2 Middle East and Africa Antibody-drug Conjugates Revenue by Country (2016-2027)
        6.3.3 Turkey
        6.3.4 Saudi Arabia
        6.3.5 U.A.E

11 Company Profiles
    11.1 ImmunoGen
        11.1.1 ImmunoGen Corporation Information
        11.1.2 ImmunoGen Overview
        11.1.3 ImmunoGen Antibody-drug Conjugates Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 ImmunoGen Antibody-drug Conjugates Product Description
        11.1.5 ImmunoGen Related Developments
    11.2 Seattle Genetics
        11.2.1 Seattle Genetics Corporation Information
        11.2.2 Seattle Genetics Overview
        11.2.3 Seattle Genetics Antibody-drug Conjugates Sales, Price, Revenue and Gross Margin (2016-2021)
        11.2.4 Seattle Genetics Antibody-drug Conjugates Product Description
        11.2.5 Seattle Genetics Related Developments
    11.3 Roche
        11.3.1 Roche Corporation Information
        11.3.2 Roche Overview
        11.3.3 Roche Antibody-drug Conjugates Sales, Price, Revenue and Gross Margin (2016-2021)
        11.3.4 Roche Antibody-drug Conjugates Product Description
        11.3.5 Roche Related Developments
    11.4 Takeda
        11.4.1 Takeda Corporation Information
        11.4.2 Takeda Overview
        11.4.3 Takeda Antibody-drug Conjugates Sales, Price, Revenue and Gross Margin (2016-2021)
        11.4.4 Takeda Antibody-drug Conjugates Product Description
        11.4.5 Takeda Related Developments
    11.1 ImmunoGen
        11.1.1 ImmunoGen Corporation Information
        11.1.2 ImmunoGen Overview
        11.1.3 ImmunoGen Antibody-drug Conjugates Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 ImmunoGen Antibody-drug Conjugates Product Description
        11.1.5 ImmunoGen Related Developments

12 Value Chain and Sales Channels Analysis
    12.1 Antibody-drug Conjugates Value Chain Analysis
    12.2 Antibody-drug Conjugates Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Antibody-drug Conjugates Production Mode & Process
    12.4 Antibody-drug Conjugates Sales and Marketing
        12.4.1 Antibody-drug Conjugates Sales Channels
        12.4.2 Antibody-drug Conjugates Distributors
    12.5 Antibody-drug Conjugates Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Antibody-drug Conjugates Industry Trends
    13.2 Antibody-drug Conjugates Market Drivers
    13.3 Antibody-drug Conjugates Market Challenges
    13.4 Antibody-drug Conjugates Market Restraints

14 Key Findings in The Global Antibody-drug Conjugates Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables Table 1. Global Antibody-drug Conjugates Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Adcetris Table 3. Major Manufacturers of Kadcyla Table 4. Global Antibody-drug Conjugates Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million) Table 5. Global Antibody-drug Conjugates Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million) Table 6. Global Antibody-drug Conjugates Sales by Region (2016-2021) & (Kg) Table 7. Global Antibody-drug Conjugates Sales Market Share by Region (2016-2021) Table 8. Global Antibody-drug Conjugates Sales by Region (2016-2021) & (Kg) Table 9. Global Antibody-drug Conjugates Sales Market Share by Region (2022-2027) Table 10. Global Antibody-drug Conjugates Revenue by Region (2016-2021) & (US$ Million) Table 11. Global Antibody-drug Conjugates Revenue Market Share by Region (2016-2021) Table 12. Global Antibody-drug Conjugates Revenue by Region (2022-2027) & (US$ Million) Table 13. Global Antibody-drug Conjugates Revenue Market Share by Region (2022-2027) Table 14. Global Antibody-drug Conjugates Sales by Manufacturers (2016-2021) & (Kg) Table 15. Global Antibody-drug Conjugates Sales Share by Manufacturers (2016-2021) Table 16. Global Antibody-drug Conjugates Revenue by Manufacturers (2016-2021) & (US$ Million) Table 17. Global Antibody-drug Conjugates Revenue Share by Manufacturers (2016-2021) Table 18. Antibody-drug Conjugates Price by Manufacturers 2016-2021 (USD/Kg) Table 19. Global Antibody-drug Conjugates Manufacturers Market Concentration Ratio (CR5 and HHI) Table 20. Global Antibody-drug Conjugates by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody-drug Conjugates as of 2020) Table 21. Antibody-drug Conjugates Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Antibody-drug Conjugates Product Offered Table 23. Date of Manufacturers Enter into Antibody-drug Conjugates Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Antibody-drug Conjugates Sales by Type (2016-2021) & (Kg) Table 26. Global Antibody-drug Conjugates Sales by Type (2022-2027) & (Kg) Table 27. Global Antibody-drug Conjugates Sales Share by Type (2016-2021) Table 28. Global Antibody-drug Conjugates Sales Share by Type (2022-2027) Table 29. Global Antibody-drug Conjugates Revenue by Type (2016-2021) & (US$ Million) Table 30. Global Antibody-drug Conjugates Revenue by Type (2022-2027) & (US$ Million) Table 31. Global Antibody-drug Conjugates Revenue Share by Type (2016-2021) Table 32. Global Antibody-drug Conjugates Revenue Share by Type (2022-2027) Table 33. Antibody-drug Conjugates Price by Type (2016-2021) & (USD/Kg) Table 34. Global Antibody-drug Conjugates Price Forecast by Type (2022-2027) & (USD/Kg) Table 35. Global Antibody-drug Conjugates Sales by Application (2016-2021) & (Kg) Table 36. Global Antibody-drug Conjugates Sales by Application (2022-2027) & (Kg) Table 37. Global Antibody-drug Conjugates Sales Share by Application (2016-2021) Table 38. Global Antibody-drug Conjugates Sales Share by Application (2022-2027) Table 39. Global Antibody-drug Conjugates Revenue by Application (2016-2021) & (US$ Million) Table 40. Global Antibody-drug Conjugates Revenue by Application (2022-2027) & (US$ Million) Table 41. Global Antibody-drug Conjugates Revenue Share by Application (2016-2021) Table 42. Global Antibody-drug Conjugates Revenue Share by Application (2022-2027) Table 43. Antibody-drug Conjugates Price by Application (2016-2021) & (USD/Kg) Table 44. Global Antibody-drug Conjugates Price Forecast by Application (2022-2027) & (USD/Kg) Table 45. North America Antibody-drug Conjugates Sales by Type (2016-2021) & (Kg) Table 46. North America Antibody-drug Conjugates Sales by Type (2022-2027) & (Kg) Table 47. North America Antibody-drug Conjugates Revenue by Type (2016-2021) & (US$ Million) Table 48. North America Antibody-drug Conjugates Revenue by Type (2022-2027) & (US$ Million) Table 49. North America Antibody-drug Conjugates Sales by Application (2016-2021) & (Kg) Table 50. North America Antibody-drug Conjugates Sales by Application (2022-2027) & (Kg) Table 51. North America Antibody-drug Conjugates Revenue by Application (2016-2021) & (US$ Million) Table 52. North America Antibody-drug Conjugates Revenue by Application (2022-2027) & (US$ Million) Table 53. North America Antibody-drug Conjugates Sales by Country (2016-2021) & (Kg) Table 54. North America Antibody-drug Conjugates Sales by Country (2022-2027) & (Kg) Table 55. North America Antibody-drug Conjugates Revenue by Country (2016-2021) & (US$ Million) Table 56. North America Antibody-drug Conjugates Revenue by Country (2022-2027) & (US$ Million) Table 57. Europe Antibody-drug Conjugates Sales by Type (2016-2021) & (Kg) Table 58. Europe Antibody-drug Conjugates Sales by Type (2022-2027) & (Kg) Table 59. Europe Antibody-drug Conjugates Revenue by Type (2016-2021) & (US$ Million) Table 60. Europe Antibody-drug Conjugates Revenue by Type (2022-2027) & (US$ Million) Table 61. Europe Antibody-drug Conjugates Sales by Application (2016-2021) & (Kg) Table 62. Europe Antibody-drug Conjugates Sales by Application (2022-2027) & (Kg) Table 63. Europe Antibody-drug Conjugates Revenue by Application (2016-2021) & (US$ Million) Table 64. Europe Antibody-drug Conjugates Revenue by Application (2022-2027) & (US$ Million) Table 65. Europe Antibody-drug Conjugates Sales by Country (2016-2021) & (Kg) Table 66. Europe Antibody-drug Conjugates Sales by Country (2022-2027) & (Kg) Table 67. Europe Antibody-drug Conjugates Revenue by Country (2016-2021) & (US$ Million) Table 68. Europe Antibody-drug Conjugates Revenue by Country (2022-2027) & (US$ Million) Table 69. Asia Pacific Antibody-drug Conjugates Sales by Type (2016-2021) & (Kg) Table 70. Asia Pacific Antibody-drug Conjugates Sales by Type (2022-2027) & (Kg) Table 71. Asia Pacific Antibody-drug Conjugates Revenue by Type (2016-2021) & (US$ Million) Table 72. Asia Pacific Antibody-drug Conjugates Revenue by Type (2022-2027) & (US$ Million) Table 73. Asia Pacific Antibody-drug Conjugates Sales by Application (2016-2021) & (Kg) Table 74. Asia Pacific Antibody-drug Conjugates Sales by Application (2022-2027) & (Kg) Table 75. Asia Pacific Antibody-drug Conjugates Revenue by Application (2016-2021) & (US$ Million) Table 76. Asia Pacific Antibody-drug Conjugates Revenue by Application (2022-2027) & (US$ Million) Table 77. Asia Pacific Antibody-drug Conjugates Sales by Region (2016-2021) & (Kg) Table 78. Asia Pacific Antibody-drug Conjugates Sales by Region (2022-2027) & (Kg) Table 79. Asia Pacific Antibody-drug Conjugates Revenue by Region (2016-2021) & (US$ Million) Table 80. Asia Pacific Antibody-drug Conjugates Revenue by Region (2022-2027) & (US$ Million) Table 81. Latin America Antibody-drug Conjugates Sales by Type (2016-2021) & (Kg) Table 82. Latin America Antibody-drug Conjugates Sales by Type (2022-2027) & (Kg) Table 83. Latin America Antibody-drug Conjugates Revenue by Type (2016-2021) & (US$ Million) Table 84. Latin America Antibody-drug Conjugates Revenue by Type (2022-2027) & (US$ Million) Table 85. Latin America Antibody-drug Conjugates Sales by Application (2016-2021) & (Kg) Table 86. Latin America Antibody-drug Conjugates Sales by Application (2022-2027) & (Kg) Table 87. Latin America Antibody-drug Conjugates Revenue by Application (2016-2021) & (US$ Million) Table 88. Latin America Antibody-drug Conjugates Revenue by Application (2022-2027) & (US$ Million) Table 89. Latin America Antibody-drug Conjugates Sales by Country (2016-2021) & (Kg) Table 90. Latin America Antibody-drug Conjugates Sales by Country (2022-2027) & (Kg) Table 91. Latin America Antibody-drug Conjugates Revenue by Country (2016-2021) & (US$ Million) Table 92. Latin America Antibody-drug Conjugates Revenue by Country (2022-2027) & (US$ Million) Table 93. Middle East and Africa Antibody-drug Conjugates Sales by Type (2016-2021) & (Kg) Table 94. Middle East and Africa Antibody-drug Conjugates Sales by Type (2022-2027) & (Kg) Table 95. Middle East and Africa Antibody-drug Conjugates Revenue by Type (2016-2021) & (US$ Million) Table 96. Middle East and Africa Antibody-drug Conjugates Revenue by Type (2022-2027) & (US$ Million) Table 97. Middle East and Africa Antibody-drug Conjugates Sales by Application (2016-2021) & (Kg) Table 98. Middle East and Africa Antibody-drug Conjugates Sales by Application (2022-2027) & (Kg) Table 99. Middle East and Africa Antibody-drug Conjugates Revenue by Application (2016-2021) & (US$ Million) Table 100. Middle East and Africa Antibody-drug Conjugates Revenue by Application (2022-2027) & (US$ Million) Table 101. Middle East and Africa Antibody-drug Conjugates Sales by Country (2016-2021) & (Kg) Table 102. Middle East and Africa Antibody-drug Conjugates Sales by Country (2022-2027) & (Kg) Table 103. Middle East and Africa Antibody-drug Conjugates Revenue by Country (2016-2021) & (US$ Million) Table 104. Middle East and Africa Antibody-drug Conjugates Revenue by Country (2022-2027) & (US$ Million) Table 105. ImmunoGen Corporation Information Table 106. ImmunoGen Description and Major Businesses Table 107. ImmunoGen Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 108. ImmunoGen Antibody-drug Conjugates Product Table 109. ImmunoGen Recent Developments Table 110. Seattle Genetics Corporation Information Table 111. Seattle Genetics Description and Major Businesses Table 112. Seattle Genetics Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 113. Seattle Genetics Antibody-drug Conjugates Product Table 114. Seattle Genetics Recent Developments Table 115. Roche Corporation Information Table 116. Roche Description and Major Businesses Table 117. Roche Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 118. Roche Antibody-drug Conjugates Product Table 119. Roche Recent Developments Table 120. Takeda Corporation Information Table 121. Takeda Description and Major Businesses Table 122. Takeda Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 123. Takeda Antibody-drug Conjugates Product Table 124. Takeda Recent Developments Table 125. Key Raw Materials Lists Table 126. Raw Materials Key Suppliers Lists Table 127. Antibody-drug Conjugates Distributors List Table 128. Antibody-drug Conjugates Customers List Table 129. Antibody-drug Conjugates Market Trends Table 130. Antibody-drug Conjugates Market Drivers Table 131. Antibody-drug Conjugates Market Challenges Table 132. Antibody-drug Conjugates Market Restraints Table 133. Research Programs/Design for This Report Table 134. Key Data Information from Secondary Sources Table 135. Key Data Information from Primary Sources List of Figures Figure 1. Antibody-drug Conjugates Product Picture Figure 2. Global Antibody-drug Conjugates Market Share by Type in 2020 & 2027 Figure 3. Adcetris Product Picture Figure 4. Kadcyla Product Picture Figure 5. Global Antibody-drug Conjugates Sales Market Share by Application in 2020 & 2027 Figure 6. Breast Cancer Figure 7. Lymphoma Figure 8. Antibody-drug Conjugates Report Years Considered Figure 9. Global Antibody-drug Conjugates Sales 2016-2027 (Kg) Figure 10. Global Antibody-drug Conjugates Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Antibody-drug Conjugates Revenue 2016-2027 (US$ Million) Figure 12. Global Antibody-drug Conjugates Revenue Market Share by Region in Percentage: 2020 Versus 2027 Figure 13. Global Antibody-drug Conjugates Sales Market Share by Region (2016-2021) Figure 14. Global Antibody-drug Conjugates Sales Market Share by Region (2022-2027) Figure 15. North America Antibody-drug Conjugates Sales YoY (2016-2027) & (Kg) Figure 16. North America Antibody-drug Conjugates Revenue YoY (2016-2027) & (US$ Million) Figure 17. Europe Antibody-drug Conjugates Sales YoY (2016-2027) & (Kg) Figure 18. Europe Antibody-drug Conjugates Revenue YoY (2016-2027) & (US$ Million) Figure 19. Asia-Pacific Antibody-drug Conjugates Sales YoY (2016-2027) & (Kg) Figure 20. Asia-Pacific Antibody-drug Conjugates Revenue YoY (2016-2027) & (US$ Million) Figure 21. Latin America Antibody-drug Conjugates Sales YoY (2016-2027) & (Kg) Figure 22. Latin America Antibody-drug Conjugates Revenue YoY (2016-2027) & (US$ Million) Figure 23. Middle East & Africa Antibody-drug Conjugates Sales YoY (2016-2027) & (Kg) Figure 24. Middle East & Africa Antibody-drug Conjugates Revenue YoY (2016-2027) & (US$ Million) Figure 25. The Top 10 and Top 5 Players Market Share by Antibody-drug Conjugates Sales in 2020 Figure 26. The Top 10 and Top 5 Players Market Share by Antibody-drug Conjugates Revenue in 2020 Figure 27. Antibody-drug Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 28. Global Antibody-drug Conjugates Sales Market Share by Type (2016-2027) Figure 29. Global Antibody-drug Conjugates Revenue Market Share by Type (2016-2027) Figure 30. Global Antibody-drug Conjugates Sales Market Share by Application (2016-2027) Figure 31. Global Antibody-drug Conjugates Revenue Market Share by Application (2016-2027) Figure 32. North America Antibody-drug Conjugates Sales Market Share by Type (2016-2027) Figure 33. North America Antibody-drug Conjugates Revenue Market Share by Type (2016-2027) Figure 34. North America Antibody-drug Conjugates Sales Market Share by Application (2016-2027) Figure 35. North America Antibody-drug Conjugates Revenue Market Share by Application (2016-2027) Figure 36. North America Antibody-drug Conjugates Sales Share by Country (2016-2027) Figure 37. North America Antibody-drug Conjugates Revenue Share by Country (2016-2027) Figure 38. U.S. Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million) Figure 39. Canada Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million) Figure 40. Europe Antibody-drug Conjugates Sales Market Share by Type (2016-2027) Figure 41. Europe Antibody-drug Conjugates Revenue Market Share by Type (2016-2027) Figure 42. Europe Antibody-drug Conjugates Sales Market Share by Application (2016-2027) Figure 43. Europe Antibody-drug Conjugates Revenue Market Share by Application (2016-2027) Figure 44. Europe Antibody-drug Conjugates Sales Share by Country (2016-2027) Figure 45. Europe Antibody-drug Conjugates Revenue Share by Country (2016-2027) Figure 46. Germany Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million) Figure 47. France Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million) Figure 48. U.K. Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million) Figure 49. Italy Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million) Figure 50. Russia Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million) Figure 51. Asia Pacific Antibody-drug Conjugates Sales Market Share by Type (2016-2027) Figure 52. Asia Pacific Antibody-drug Conjugates Revenue Market Share by Type (2016-2027) Figure 53. Asia Pacific Antibody-drug Conjugates Sales Market Share by Application (2016-2027) Figure 54. Asia Pacific Antibody-drug Conjugates Revenue Market Share by Application (2016-2027) Figure 55. Asia Pacific Antibody-drug Conjugates Sales Share by Region (2016-2027) Figure 56. Asia Pacific Antibody-drug Conjugates Revenue Share by Region (2016-2027) Figure 57. China Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million) Figure 58. Japan Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million) Figure 59. South Korea Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million) Figure 60. India Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million) Figure 61. Australia Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million) Figure 62. Taiwan Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million) Figure 63. Indonesia Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million) Figure 64. Thailand Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million) Figure 65. Malaysia Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million) Figure 66. Philippines Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million) Figure 67. Latin America Antibody-drug Conjugates Sales Market Share by Type (2016-2027) Figure 68. Latin America Antibody-drug Conjugates Revenue Market Share by Type (2016-2027) Figure 69. Latin America Antibody-drug Conjugates Sales Market Share by Application (2016-2027) Figure 70. Latin America Antibody-drug Conjugates Revenue Market Share by Application (2016-2027) Figure 71. Latin America Antibody-drug Conjugates Sales Share by Country (2016-2027) Figure 72. Latin America Antibody-drug Conjugates Revenue Share by Country (2016-2027) Figure 73. Mexico Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million) Figure 74. Brazil Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million) Figure 75. Argentina Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million) Figure 76. Middle East and Africa Antibody-drug Conjugates Sales Market Share by Type (2016-2027) Figure 77. Middle East and Africa Antibody-drug Conjugates Revenue Market Share by Type (2016-2027) Figure 78. Middle East and Africa Antibody-drug Conjugates Sales Market Share by Application (2016-2027) Figure 79. Middle East and Africa Antibody-drug Conjugates Revenue Market Share by Application (2016-2027) Figure 80. Middle East and Africa Antibody-drug Conjugates Sales Share by Country (2016-2027) Figure 81. Middle East and Africa Antibody-drug Conjugates Revenue Share by Country (2016-2027) Figure 82. Turkey Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million) Figure 83. Saudi Arabia Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million) Figure 84. U.A.E Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million) Figure 85. Antibody-drug Conjugates Value Chain Figure 86. Antibody-drug Conjugates Production Process Figure 87. Channels of Distribution Figure 88. Distributors Profiles Figure 89. Bottom-up and Top-down Approaches for This Report Figure 90. Data Triangulation Figure 91. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us